Publications
5677 Results
- Journal / Conference
- Journal of Clinical Oncology Jun 20;41(18):3352-3362
- Year
- 2023
- Research Committee(s)
- Genitourinary
- PMID
- PMID36996380
- Study Number(s)
- CTSU/A031201
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
- Journal / Conference
- New England Journal of Medicine
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID37272534
- PMC
- PMC10775881
- Study Number(s)
- CTSU/N1048
Preoperative Treatment of Locally Advanced Rectal Cancer
- Journal / Conference
- Journal of Clinical Oncology
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID37270691
- PMC
- PMC10351948
- Study Number(s)
- CTSU/N1048
Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the N1048 PROSPECT trial
- Journal / Conference
- CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Year
- 2023
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response
- Journal / Conference
- EUROPEAN UROLOGY
- Year
- 2023
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID36872133
- PMC
- PMC10424812
- Study Number(s)
- S0000, SWOG-9217
Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry
- Journal / Conference
- JCO Precision Oncology
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID37487150
- PMC
- PMC10581628
- Study Number(s)
- CTSU/C80405
Transcriptional Profiling and Consensus Molecular Subtype Assignment to Understand Response and Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Colorectal Cancer
- Journal / Conference
- Br J Sports Med. Aug;57(15):965-971
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36878665
- PMC
- PMC19423490
- Study Number(s)
- CTSU/C80702
Association between physical activity and the time course of cancer recurrence in stage III colon cancer
- Journal / Conference
- CLINICAL CANCER RESEARCH
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID37289007
- PMC
- PMC10524689
- Study Number(s)
- CTSU/C80702
Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
- Journal / Conference
- Journal of Clinical Oncology
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36260828
- PMC
- PMC9995105
- Study Number(s)
- CTSU/E2211
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
- Journal / Conference
- Journal of Geriatric Oncology
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID37329769
- Study Number(s)
- CTSU/A041202